Literature DB >> 24891344

Palbociclib ups PFS in HER2-/ER+ breast cancer.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24891344     DOI: 10.1158/2159-8290.CD-NB2014-053

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


× No keyword cloud information.
  5 in total

1.  Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma.

Authors:  David Chiron; Maurizio Di Liberto; Peter Martin; Xiangao Huang; Jeff Sharman; Pedro Blecua; Susan Mathew; Priyanka Vijay; Ken Eng; Siraj Ali; Amy Johnson; Betty Chang; Scott Ely; Olivier Elemento; Christopher E Mason; John P Leonard; Selina Chen-Kiang
Journal:  Cancer Discov       Date:  2014-07-31       Impact factor: 39.397

2.  CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer.

Authors:  Jorge Franco; Agnieszka K Witkiewicz; Erik S Knudsen
Journal:  Oncotarget       Date:  2014-08-15

3.  Breakthrough cancer medicine and its impact on novel drug development in China: report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting.

Authors:  Feng Roger Luo; Jian Ding; Helen X Chen; Hao Liu; Man-Cheong Fung; Maria Koehler; Jean Pierre Armand; Lei Jiang; Xiao Xu; Ge Zhang; Li Xu; Pascal Qian; Li Yan
Journal:  Chin J Cancer       Date:  2014-11-21

Review 4.  Pathogenesis and heterogeneity of ovarian cancer.

Authors:  Paul T Kroeger; Ronny Drapkin
Journal:  Curr Opin Obstet Gynecol       Date:  2017-02       Impact factor: 1.927

5.  Effective combination therapies in preclinical endocrine resistant breast cancer models harboring ER mutations.

Authors:  Brendon Ladd; Anne Marie Mazzola; Teeru Bihani; Zhongwu Lai; James Bradford; Michael Collins; Evan Barry; Anne U Goeppert; Hazel M Weir; Kelly Hearne; Jonathan G Renshaw; Morvarid Mohseni; Elaine Hurt; Sanjoo Jalla; Haifeng Bao; Robert Hollingsworth; Corinne Reimer; Michael Zinda; Stephen Fawell; Celina M D'Cruz
Journal:  Oncotarget       Date:  2016-08-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.